跳至主要内容
临床试验/ACTRN12620000724976
ACTRN12620000724976已完成未知

Prolonged administration of Intravenous Medication through Midline compared to Standard peripheral intravenous cannula in children to reduce catheter failure.

Queenland Children's Hospital0 个研究点目标入组 128 人开始时间: 2020年7月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
12 Months 至 18 Years(—)
性别
All

入选标准

  • 1. Between 12 months and 18 years of age
  • 2. greater than 2.5mm upper arm vein
  • 3. The treating team have indicated that the patient is expected to require 4 or more days of peripherally compatible intravenous therapy
  • 4. Informed consent to participate
  • 5. Require the insertion of a new intravenous access device

排除标准

  • 1.Presence of a co-existent central venous access device
  • 2.Non-English speakers without an interpreter
  • 3.Children under care of department of communities or without a legal guardian
  • 4.Thrombosed vessels in the upper arm distal to the axillar
  • 5.Patient receiving end-of-life care
  • 6.Previous enrolment in this study

研究者

发起方
Queenland Children's Hospital

相似试验